ACCC | Observed Survival Benefit with Limited Exposure of Durvalumab in Unresectable Stage III Non-Small Cell Lung Cancer at a Large Community-Based Institution
Observed Survival Benefit with Limited Exposure of Durvalumab in Unresectable Stage III Non-Small Cell Lung Cancer at a Large Community-Based Institution
Upcoming Events
ACCC 43rd National Oncology Conference
In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
In Person Conference & ConventionOctober 3, 2026 at 7:30 AM EDT8787 Keystone Crossing, Indianapolis, IN, USASheraton Indianapolis Hotel at Keystone Crossing, Indianapolis
In Person Conference & ConventionOctober 15, 2026 at 5:30 PM PDT255 N Virginia St, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton, Reno
